Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

Women (1)

Filter by Topic

Treatment (remove)
- HIV drugs (remove)
  - Atazanavir (Reyataz) (remove)
  - Darunavir (Prezista) (2)
  - Kaletra (lopinavir/ritonavir) (2)
  - Ritonavir (Norvir) (2)
  - Tenofovir (viread) (2)
  - Biktarvy (1)
  - Dolutegravir (Tivicay) (1)
  - Raltegravir (Isentress, Isentress HD) (1)
- Side effects (2)
- Drug treatment strategies (1)
Organ and body health (2)
Reproductive and maternal health (2)

Filter by Infection

HIV (remove)

Filter by Resource Category

Research summary (remove)

Search results

Current filters: HIV, Treatment, Research summary, HIV drugs, Atazanavir (Reyataz)

6 search results

Switching to Biktarvy from a protease inhibitor–based regimen: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Dolutegravir—Interaction with atazanavir during pregnancy: From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage
U.S. analysis of the safety of ART during pregnancy: From TreatmentUpdate 206
2015, CATIE
Research summary - Webpage
Comparing the tolerability and effectiveness of initial therapy: From TreatmentUpdate 202
2014, CATIE
Research summary - Webpage
Putting reports of kidney injury into perspective: From TreatmentUpdate 195
2013, CATIE
Research summary - Webpage
Kidney injury and anti-HIV drugs – the latest from the DAD study: From TreatmentUpdate 195
2013, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.